FAMU Class of 2025 Doctor of Pharmacy Graduates Excel on NAPLEX and MPJE, CoPPS, IPH Reports
TALLAHASSEE, Fla. — Florida A&M University’s College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health (CoPPS, IPH) announced substantial improvements in licensure examination outcomes for the Doctor of Pharmacy Class of 2025, according to newly released performance reports from the National Association of Boards of Pharmacy (NABP).
“Florida A&M University is committed to building a stronger pipeline of skilled talent who are prepared for careers in critical health professions,” said President Marva B. Johnson, J.D. “The exceptional performance of our pharmacy graduates on the licensure and board exams demonstrates our focus on post-graduation readiness and holistic student development through all phases of the academic experience.”
The cohort achieved an 89.8% first time pass rate on the North American Pharmacist Licensure Examination (NAPLEX), marking a substantial increase from 69.3% the previous year. This more than 20 percentage point gain places FAMU graduates above both state and national averages.
The performance on the Multistate Pharmacy Jurisprudence Examination (MPJE) also demonstrated continued progress. The Class of 2025 recorded a 56.5% first time pass rate, up from 55.7% for the previous cohort. When considering all attempts, MPJE performance reached 62.1%, reflecting strong persistence and successful remediation across testing windows and jurisdictions.
“These remarkable gains in NAPLEX and MPJE performance reflect the power of academic excellence, accountability, and a shared dedication to preparing our graduates for professional impact,” said Donald Palm, III, Ph.D., executive vice president for Health Sciences Enterprise and Research Innovation. “Congratulations to Provost Watson, Dean Ablordeppey, and the outstanding faculty of FAMU’s College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health for their exceptional leadership and unwavering commitment to student success.”
FAMU CoPPS, IPH Interim Dean Seth Ablordeppey, Ph.D., noted these results reflect the unwavering commitment of our faculty, staff and students to academic excellence and professional readiness.
“The significant gains in NAPLEX and MPJE performance demonstrate what is possible when data‑driven instruction, early intervention and intentional student support come together with determination and hard work. We are proud of the Class of 2025 and grateful to every member of our college community who contributed to this progress. As we continue strengthening our programs, we remain focused on preparing practice‑ready graduates who will lead with competence, compassion and integrity in the communities they serve,” said Ablordeppey.
The college credits the improvements to coordinated academic interventions, enhanced accountability structures, and expanded support for students navigating the licensure process.
“These results underscore the effectiveness of our targeted, data driven strategies to strengthen licensure readiness,” said Jocelyn D. Spates, PharmD, associate dean of clinical affairs. “Integrated board preparation, early diagnostic assessments, increased faculty engagement, and the Resources to Increase Success on Licensure (RISE) program have all contributed to this upward trajectory. We are proud of our graduates and grateful to the faculty and staff whose commitment made this progress possible.”
For more information about FAMU CoPPS, IPH programs and licensure preparation initiatives, visit www.pharmacy.famu.edu.
Media Contact:
Rachel James-Terry
Senior Director of Strategic Communications
rachel.jamesterry@famu.edu
